Affiliations 

  • 1 Research Institute of Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan
  • 2 Research Institute of Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan. Electronic address: [email protected]
  • 3 Department of Chemistry, University of Sahiwal, Sahiwal 57000, Pakistan
  • 4 Department of Civil Engineering, Umm Al Qura University, Makkah, Saudi Arabia
  • 5 Center for Advanced Drug Research, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan
  • 6 Faculty of Pharmacy, Universiti Teknologi MARA Cawangan Selangor Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor D. E., Malaysia; Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA Cawangan Selangor Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor D. E., Malaysia
  • 7 Department of Chemistry, Umm Al-Qura University, Makkah, Saudi Arabia
Bioorg Chem, 2021 10;115:105209.
PMID: 34364054 DOI: 10.1016/j.bioorg.2021.105209

Abstract

A series of semicarbazone, thiosemicarbazone, thiazole, and oxazole derivatives were designed, synthesized, and examined for monoamine oxidase inhibition using two isoforms, i.e., MAO-A and MAO-B. Among all the analogues, 3c and 3j possessed substantial activity against MAO-A with IC50 values of 5.619 ± 1.04 µM and 0.5781 ± 0.1674 µM, respectively. Whereas 3d and 3j were active against monoamine oxidase B with the IC50 values of 9.952 ± 1.831 µM and 3.5 ± 0.7 µM, respectively. Other derivatives active against MAO-B were 3c and 3g with the IC50 values of 17.67 ± 5.6 µM and 37.18 ± 2.485 µM. Moreover, molecular docking studies were achieved for the most potent compound (3j) contrary to human MAO-A and MAO-B. Kinetic studies were also performed for the most potent analogue to evaluate its mode of interaction with MAO-A and MAO-B.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.